Endometrial Cancer [clinicaltrials_resource:30f7f64ea425f5baa8901c5458007306]
Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus [clinicaltrials:NCT00002459]High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma [clinicaltrials:NCT00002465]Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer [clinicaltrials:NCT00002493]Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00002641]Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma [clinicaltrials:NCT00002764]Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone Surgery [clinicaltrials:NCT00002807]clinicaltrials:NCT00002920clinicaltrials:NCT00002949Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer [clinicaltrials:NCT00002976]clinicaltrials:NCT00003127Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer [clinicaltrials:NCT00003135]Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer [clinicaltrials:NCT00003179]Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer [clinicaltrials:NCT00003267]Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract [clinicaltrials:NCT00003334]Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00003560]Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [clinicaltrials:NCT00003624]Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer [clinicaltrials:NCT00003669]Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [clinicaltrials:NCT00003691]Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma [clinicaltrials:NCT00003718]Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer [clinicaltrials:NCT00003749]Quality of Life in Survivors of Gynecologic Cancer [clinicaltrials:NCT00003795]Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer [clinicaltrials:NCT00003821]Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma [clinicaltrials:NCT00003939]Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer [clinicaltrials:NCT00003946]Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors [clinicaltrials:NCT00004082]Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer [clinicaltrials:NCT00004251]Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer [clinicaltrials:NCT00004915]Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer [clinicaltrials:NCT00005031]clinicaltrials:NCT00005095Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer [clinicaltrials:NCT00005583]Chemotherapy in Treating Patients With Sarcoma of the Uterus [clinicaltrials:NCT00005643]Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer [clinicaltrials:NCT00005861]Thalidomide in Treating Patients With Gynecologic Sarcomas [clinicaltrials:NCT00006005]Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer [clinicaltrials:NCT00006027]STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma [clinicaltrials:NCT00006357]Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer [clinicaltrials:NCT00006377]clinicaltrials:NCT00006903Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors [clinicaltrials:NCT00010829]Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer [clinicaltrials:NCT00016341]Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors [clinicaltrials:NCT00019331]
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Endometrial Cancer [clinicaltrials_resource:30f7f64ea425f5baa8901c5458007306]
Bio2RDF identifier
30f7f64ea425f5baa8901c5458007306
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:30f7f64ea425f5baa8901c5458007306
identifier
clinicaltrials_resource:30f7f64ea425f5baa8901c5458007306
title
Endometrial Cancer
@en
label
Endometrial Cancer [clinicaltrials_resource:30f7f64ea425f5baa8901c5458007306]
@en